rivastigmine
Ligand Summary
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
PubChem: 77991
Guide to Pharmacology: 6602
ChEMBL: CHEMBL636
DrugCentral: 2392
LyCHI: WQ3RHUYHGTKM
Target Activities
41 Activities
Items per page:
1 – 10 of 41
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||